COMMUNITY HEALTH SYSTEMS INC CYH Cash Flow

Community health systems inc (CYH)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10
Cash flows from operating activities:
Net income (loss)
-455	-590	-543	-852	-799	-704	-2,411	-2,195	-2,225	-2,396	-589	-554	-1,839	-1,626	-1,476	-1,344	196	259	444	462	400	203	119	47	23	217	250	287	342	346	313	347	298	277	316	308	341	348	0	0	0
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization
599	608	625	647	672	700	727	761	806	861	926	984	1,038	1,100	1,137	1,160	1,176	1,174	1,166	1,158	1,181	1,187	1,097	1,013	893	783	772	758	743	726	708	687	670	657	643	633	623	609	0	0	0
Deferred income taxes
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Government and other legal settlements and related costs
48	51	27	13	11	11	10	10	15	9	0	0	0	-	-	-	-	4	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation expense
9	10	11	12	12	13	14	16	19	24	30	35	41	46	51	55	59	59	62	62	57	54	45	41	39	38	39	39	40	41	41	42	43	42	40	39	38	38	0	0	0
Loss on sale, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-4	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-2	0	0	0	-	-	-	-
Impairment of hospitals sold or held for sale
-	-	-	-	-	-	-	-	-	-	-	-	-	8	-2	4	4	5	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	47	0	0	0	-	-	-	-
Impairment and loss on sale of businesses, net
145	138	424	537	678	668	2,074	1,995	1,901	2,123	587	593	2,152	1,919	0	0	0	-	-	-	-	41	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from early extinguishment of debt
-27	-54	-32	-59	4	31	27	50	-23	-40	0	0	0	-	-	-	-	-16	-16	-16	-8	-73	-73	-73	-73	-1	-0	-52	-52	-115	0	0	0	-	-	-	0	-	-	-	-
Excess tax benefit relating to stock-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	4	5	7	9	8	7	4	2	1	1	5	4	4	10	10	0	0	0
Other non-cash expenses, net
-195	-182	-153	-116	-62	-38	-36	-40	-39	-35	-36	-27	-25	-31	-44	-70	-68	-47	-1	7	0	-13	-143	-107	-73	-61	58	43	36	33	36	40	42	28	18	19	5	12	0	0	0
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:
Patient accounts receivable
-261	-93	-75	-45	-87	-31	-541	-525	-655	-732	-173	-130	-24	96	-32	171	126	219	298	228	337	306	353	345	308	285	207	110	188	204	275	254	245	138	92	46	-10	27	0	0	0
Supplies, prepaid expenses and other current assets
29	-38	-42	-103	-51	-16	-18	-7	-13	33	76	61	28	-25	-68	7	96	68	5	40	-28	-28	-13	-15	-8	8	90	44	-24	99	79	92	182	42	76	29	18	39	0	0	0
Accounts payable, accrued liabilities and income taxes
-252	-157	-431	172	-113	-163	99	-251	-88	-69	-96	-51	-215	-137	-495	-452	-130	-478	97	-36	-54	147	93	201	91	76	-63	14	51	246	203	168	357	246	135	177	-20	161	0	0	0
Other
252	245	121	138	93	36	31	41	73	105	-7	43	-24	-31	58	30	70	53	85	48	65	83	56	34	8	-25	-30	-10	8	-17	14	13	-3	27	19	14	2	2	0	0	0
Net cash provided by operating activities
309	385	25	445	301	274	596	364	637	773	944	1,008	1,085	1,137	1,116	1,049	1,276	921	1,591	1,605	1,489	1,615	1,287	1,294	1,097	1,089	943	1,106	1,149	1,280	1,219	1,160	1,261	1,261	1,110	1,231	1,076	1,188	0	0	0
Cash flows from investing activities:
Acquisitions of facilities and other related businesses
-	13	18	29	22	26	23	12	12	6	5	13	26	123	138	144	143	57	91	77	330	3,091	3,051	3,075	2,813	44	43	86	78	322	518	456	618	415	390	450	293	248	0	0	0
Purchases of property and equipment
416	438	436	444	478	527	549	585	588	564	611	611	666	744	818	886	936	953	989	966	913	853	753	680	682	614	632	677	697	769	801	811	807	776	818	754	694	667	0	0	0
Proceeds from disposition of hospitals and other ancillary operations
445	604	540	478	555	405	0	0	0	-	-	-	-	143	80	105	105	155	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	173	0	0	0	-	-	-	-
Proceeds from sale of property and equipment
-	-	-	-	-	8	0	0	0	-	-	-	-	15	12	11	16	15	0	0	0	-	-	-	-	7	5	4	6	6	6	6	4	11	14	14	15	8	0	0	0
Purchases of available-for-sale debt securities and equity securities
82	80	86	79	74	78	90	126	132	125	195	479	480	505	430	135	140	162	192	216	244	263	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sales of available-for-sale debt securities and equity securities
81	92	111	103	112	114	150	224	216	208	211	278	450	464	419	303	140	156	161	192	209	229	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Increase in other investments
152	170	211	185	147	141	124	136	134	143	136	189	212	242	270	238	233	205	260	340	451	511	493	456	370	340	309	270	299	298	279	275	223	188	169	148	132	137	0	0	0
Net cash (used in) provided by investing activities
-130	-2	-98	-151	-49	-245	-372	232	1,063	1,069	1,070	49	830	630	477	638	-1,191	-1,051	-1,185	-1,211	-1,526	-4,351	-4,249	-4,205	-3,861	-991	-980	-1,030	-1,068	-1,383	-1,592	-1,381	-1,486	-1,195	-1,190	-1,320	-1,090	-1,044	0	0	0
Cash flows from financing activities:
Proceeds from exercise of stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	25	47	73	76	65	43	20	44	110	123	122	91	20	5	1	1	18	21	22	51	56	0	0	0
Repurchase of restricted stock shares for payroll tax withholding requirements
1	1	1	1	1	1	1	1	1	5	6	6	4	6	5	5	7	20	20	20	20	11	11	11	12	15	14	14	13	9	0	0	0	-	-	-	-	-	-	-	-
Stock buy-back
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	27	0	0	0	-	-	-	-	-	-	-	-	113	0	0	0
Deferred financing costs and other debt-related costs
53	46	31	70	110	96	93	58	37	66	0	0	0	-	-	-	-	30	34	37	27	276	272	281	281	13	18	78	117	141	0	0	0	-	-	-	-	-	-	-	-
Excess tax benefit relating to stock-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	4	5	7	9	8	7	4	2	1	1	5	4	4	10	10	0	0	0
Proceeds from noncontrolling investors in joint ventures
-	10	0	0	0	-	-	-	-	5	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	3	2	6	7	0	0	0
Redemption of noncontrolling investments in joint ventures
12	11	10	27	29	31	28	8	5	6	5	7	7	19	37	38	45	36	168	166	160	158	0	0	0	-	-	-	-	44	47	45	43	13	0	0	0	-	-	-	-
Distributions to noncontrolling investors in joint ventures
102	99	100	101	100	96	95	99	95	100	102	98	102	92	100	99	95	100	99	108	108	104	90	82	80	76	67	71	55	68	66	60	67	56	76	68	66	68	0	0	0
Proceeds from sale-lease back
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other borrowings
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Borrowings under credit agreements
-	-	-	-	-	28	26	27	241	841	1,789	2,913	3,925	4,879	5,387	5,343	5,235	4,922	4,247	4,028	3,303	9,131	8,728	8,386	8,172	1,194	815	638	1,372	3,976	0	0	0	-	-	-	0	-	-	-	-
Issuance of long-term debt
2,664	3,042	0	0	0	-	-	-	-	3,100	0	0	0	-	-	-	-	-	-	-	-	4,000	0	0	0	-	-	-	-	3,825	0	0	0	-	-	-	0	-	-	-	-
Proceeds from ABL facility
717	202	235	235	773	797	666	666	128	105	67	102	102	107	160	146	162	206	112	162	146	204	222	171	171	338	370	350	350	350	0	0	0	-	-	-	0	-	-	-	-
Repayments of long-term indebtedness
3,533	3,557	2,784	3,427	3,839	2,033	1,989	1,684	2,654	5,391	6,494	6,852	8,061	6,715	6,918	6,807	5,262	5,050	4,513	4,338	3,562	9,980	9,584	9,153	8,905	1,622	1,217	3,637	4,306	7,530	8,964	6,147	5,263	1,651	143	56	62	61	0	0	0
Net cash provided by (used in) financing activities
-210	-363	-105	-295	-399	-396	-479	-1,156	-1,523	-1,517	-1,557	-750	-1,849	-1,713	-1,646	-1,591	-126	-195	-441	-418	-354	2,872	0	0	0	-	-	60	74	361	346	145	83	-235	-221	-268	-195	-189	0	0	0
Net change in cash and cash equivalents
-31	20	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net change in cash and cash equivalents
-	-	-	-	-	-	-	-	177	-	457	307	66	54	-53	96	-41	-325	-35	-24	-391	136	77	138	328	-15	-96	135	155	258	-25	-76	-141	-169	-301	-357	-209	-45	0	0	0
Supplemental disclosure of cash flow information:
Interest payments
1,086	1,011	1,109	768	913	936	859	929	785	852	793	850	902	930	940	955	932	925	922	938	956	831	798	639	608	583	578	558	582	594	593	684	615	680	649	658	656	650	0	0	0
Income tax refunds (payments), net
0	-	-	-	-	-	-	-	-	-4	15	18	16	16	8	7	11	12	-81	-98	-100	-180	-88	-70	-7	73	72	103	57	56	84	74	25	26	-3	22	127	128	0	0	0